Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of Fresenius Medical Care AG & Co. KGAA (NYSE:  FMS) violated securities laws in connection with certain financial statements.

The investigation seeks to discover if possible claims on behalf of purchasers of the securities of Fresenius Medical Care AG & Co. KGAA (NYSE:  FMS)  concerning whether a series of statements by Fresenius Medical Care AG & Co. KGAA regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On January 7, 2017, the Company revealed that its U.S. unit had received subpoenas from federal prosecutors seeking for information about its relation with the American Kidney Fund, a charity that helps patients pay for kidney dialysis. 

Following this news, NYSE:  FMS fell 7.26% on January 9, 2017.

Based in Bad Homburg, Germany, and founded in 1996 Fresenius Medical Care AG & Co. KGAA provides dialysis treatment and related dialysis care services, and other health care services.

If you purchased shares of Fresenius Medical Care AG & Co. KGAA (NYSE:  FMS) on or before January 7, 2017, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185